Clinical Trial Update: Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial of oral BT-11 in moderate to severe Crohn's disease was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• BT-11

Snippet

Sponsor: NImmune Biopharma | Conditions: Crohn's Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-12-04